(Q67823700)

English

Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure

scientific article published on 01 October 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Anesthesiology and pain medicine

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

author name string

Russell K. Portenoy

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771088

19 November 2022

Kathleen M. Foley

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771088

19 November 2022

James Stulman

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771088

19 November 2022

Elizabeth Khan

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771088

19 November 2022

Jean Adelhardt

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771088

19 November 2022

Mary Layman

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771088

19 November 2022

Daniel F. Cerbone

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771088

19 November 2022

Charles E. Inturrisi

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771088

19 November 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1771088

19 November 2022

publication date

1 October 1991

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

full work available at URL

https://journals.lww.com/10.1016/0304-3959(91)90005-I

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

47

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

13-19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats.

1

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Persistently increased morphine-6-glucuronide concentrations

2

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Chronic nausea and morphine-6-glucuronide

3

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Potential analgesic contribution from morphine-6-glucuronide in CSF

4

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine

5

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Central nervous system excitatory effects of meperidine in cancer patients

8

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Potency of oral morphine

9

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Morphine intoxication in renal failure: the role of morphine-6-glucuronide

11

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Analgesic activity of morphine-6-glucuronide

12

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide

13

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Morphine-6-glucuronide, a potent mu agonist.

14

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration

16

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Relative bioavailability of controlled release morphine tablets (MST continus) in cancer patients

17

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment

18

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Kinetics of morphine in patients with renal failure

20

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Morphine metabolism in cancer patients on increasing oral doses--no evidence for autoinduction or dose-dependence

21

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Kinetics of morphine in patients with renal failure

22

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Studies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites

23

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Analgesic Effect of Morphine Glucuronides

24

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography

26

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Influence of renal function on the elimination of morphine and morphine glucuronides.

27

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Renal failure does not impair the metabolism of morphine

28

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Identifiers

10.1016/0304-3959(91)90005-I

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67823700&oldid=1775115562"